-
1
-
-
0029925931
-
Impact of the in-vitro fertilization process on emotional, physical and relational variables
-
Boivin, J. & Takefman, J.E. Impact of the in-vitro fertilization process on emotional, physical and relational variables. Hum. Reprod. 11, 903-907 (1996).
-
(1996)
Hum. Reprod.
, vol.11
, pp. 903-907
-
-
Boivin, J.1
Takefman, J.E.2
-
2
-
-
0035988486
-
Single dose pharmacokinetics and efects on follicular growth and serum hormones of a long-acting recombinant FSH preparation (FSH-CTP) in healthy pituitary-suppressed females
-
Duijkers, I.J., Klipping, C., Boerrigter, P.J., Machielsen, C.S., De Bie, J.J. & Voortman, G. Single dose pharmacokinetics and efects on follicular growth and serum hormones of a long-acting recombinant FSH preparation (FSH-CTP) in healthy pituitary-suppressed females. Hum. Reprod. 17, 1987-1993 (2002).
-
(2002)
Hum. Reprod.
, vol.17
, pp. 1987-1993
-
-
Duijkers, I.J.1
Klipping, C.2
Boerrigter, P.J.3
MacHielsen, C.S.4
De Bie, J.J.5
Voortman, G.6
-
3
-
-
0026551294
-
Design of a long-acting follitropin agonist by fusing the C-terminal sequence of the chorionic gonadotropin beta subunit to the follitropin beta subunit
-
Fares, F.A., Suganuma, N., Nishimori, K., LaPolt, P.S., Hsueh, A.J. & Boime, I. Design of a long-acting follitropin agonist by fusing the C-terminal sequence of the chorionic gonadotropin beta subunit to the follitropin beta subunit. Proc. Natl. Acad. Sci. U.S.A. 89, 4304-4308 (1992).
-
(1992)
Proc. Natl. Acad. Sci. U.S.A.
, vol.89
, pp. 4304-4308
-
-
Fares, F.A.1
Suganuma, N.2
Nishimori, K.3
Lapolt, P.S.4
Hsueh, A.J.5
Boime, I.6
-
4
-
-
2442425992
-
Induction of multiple follicular development by a single dose of long-acting recombinant follicle-stimulating hormone (FSH-CTP, corifollitropin alfa) for controlled ovarian stimulation before in vitro fertilization
-
Devroey, P., Fauser, B.C., Platteau, P., Beckers, N.G., Dhont, M. & Mannaerts, B.M. Induction of multiple follicular development by a single dose of long-acting recombinant follicle-stimulating hormone (FSH-CTP, corifollitropin alfa) for controlled ovarian stimulation before in vitro fertilization. J. Clin. Endocrinol. Metab. 89, 2062-2070 (2004)
-
(2004)
J. Clin. Endocrinol. Metab.
, vol.89
, pp. 2062-2070
-
-
Devroey, P.1
Fauser, B.C.2
Platteau, P.3
Beckers, N.G.4
Dhont, M.5
Mannaerts, B.M.6
-
5
-
-
54149099792
-
A randomized dose-response trial of a single injection of corifollitropin alfa to sustain multifollicular growth during controlled ovarian stimulation
-
The Corifollitropin Alfa Dose-Finding Study Group
-
The Corifollitropin Alfa Dose-Finding Study Group. A randomized dose-response trial of a single injection of corifollitropin alfa to sustain multifollicular growth during controlled ovarian stimulation. Hum. Reprod. 23, 2484-2492 (2008).
-
(2008)
Hum. Reprod.
, vol.23
, pp. 2484-2492
-
-
-
6
-
-
0035989359
-
Day 5 inhibin B levels in a treatment cycle are predictive of IVF outcome
-
Fawzy, M. et al. Day 5 inhibin B levels in a treatment cycle are predictive of IVF outcome. Hum. Reprod. 17, 1535-1543 (2002).
-
(2002)
Hum. Reprod.
, vol.17
, pp. 1535-1543
-
-
Fawzy, M.1
-
7
-
-
27944501145
-
Dynamic assays of inhibin B, anti-Mullerian hormone and estradiol following FSH stimulation and ovarian ultrasonography as predictors of IVF outcome
-
Eldar-Geva, T. et al. Dynamic assays of inhibin B, anti-Mullerian hormone and estradiol following FSH stimulation and ovarian ultrasonography as predictors of IVF outcome. Hum. Reprod. 20, 3178-3183 (2005).
-
(2005)
Hum. Reprod.
, vol.20
, pp. 3178-3183
-
-
Eldar-Geva, T.1
-
8
-
-
0036712130
-
Serum inhibin B levels measured early during FSH administration for IVF may be of value in predicting the number of oocytes to be retrieved in normal and low responders
-
Eldar-Geva, T. et al. Serum inhibin B levels measured early during FSH administration for IVF may be of value in predicting the number of oocytes to be retrieved in normal and low responders. Hum. Reprod. 17, 2331-2337 (2002).
-
(2002)
Hum. Reprod.
, vol.17
, pp. 2331-2337
-
-
Eldar-Geva, T.1
-
9
-
-
0034453913
-
Relationship between serum inhibin A and B and ovarian follicle development after a daily fxed dose administration of recombinant follicle-stimulating hormone
-
Eldar-Geva, T. et al. Relationship between serum inhibin A and B and ovarian follicle development after a daily fxed dose administration of recombinant follicle-stimulating hormone. J. Clin. Endocrinol. Metab. 85, 607-613 (2000).
-
(2000)
J. Clin. Endocrinol. Metab.
, vol.85
, pp. 607-613
-
-
Eldar-Geva, T.1
-
10
-
-
0031426576
-
A population model for the follicular growth in women treated with follicle stimulating hormone
-
Karlsson, M.O., Wade, J.R., Loumaye, E. & Munafo, A. A population model for the follicular growth in women treated with follicle stimulating hormone. Clin. Pharmacol. Ther. 62, 665-674 (1997).
-
(1997)
Clin. Pharmacol. Ther.
, vol.62
, pp. 665-674
-
-
Karlsson, M.O.1
Wade, J.R.2
Loumaye, E.3
Munafo, A.4
-
11
-
-
0029995406
-
Oestradiol and immunoreactive inhibin-like secretory patterns following controlled ovarian hyperstimulation with urinary (Metrodin) or recombinant follicle stimulating hormone (Puregon)
-
Mitchell, R. et al. Oestradiol and immunoreactive inhibin-like secretory patterns following controlled ovarian hyperstimulation with urinary (Metrodin) or recombinant follicle stimulating hormone (Puregon). Hum. Reprod. 11, 962-967 (1996).
-
(1996)
Hum. Reprod.
, vol.11
, pp. 962-967
-
-
Mitchell, R.1
-
12
-
-
72949112470
-
A double-blind, non-inferiority RCT comparing corifollitropin alfa and recombinant FSH during the frst seven days of ovarian stimulation using a GnRH antagonist protocol
-
ENGAGE Investigators
-
Devroey, P., Boostanfar, R., Koper, N.P., Mannaerts, B.M., Ijzerman-Boon, P.C. & Fauser, B.C.; ENGAGE Investigators. A double-blind, non-inferiority RCT comparing corifollitropin alfa and recombinant FSH during the frst seven days of ovarian stimulation using a GnRH antagonist protocol. Hum. Reprod. 24, 3063-3072 (2009).
-
(2009)
Hum. Reprod.
, vol.24
, pp. 3063-3072
-
-
Devroey, P.1
Boostanfar, R.2
Koper, N.P.3
Mannaerts, B.M.4
Ijzerman-Boon, P.C.5
Fauser, B.C.6
-
13
-
-
77953807878
-
Corifollitropin alfa for controlled ovarian stimulation in IVF treatment: Results from a randomized trial in lower body weight women
-
Corifollitropin alfa ENSURE study group Online, in press.
-
Mannaerts, B.; Corifollitropin alfa ENSURE study group. Corifollitropin alfa for controlled ovarian stimulation in IVF treatment: results from a randomized trial in lower body weight women. Reprod. Biomed. Online, in press.
-
Reprod. Biomed
-
-
Mannaerts, B.1
-
14
-
-
10344231983
-
Pharmacodynamics of a single low dose of long-acting recombinant follicle-stimulating hormone (FSH-carboxy terminal peptide, corifollitropin alfa) in women with World Health Organization group II anovulatory infertility
-
Balen, A.H. et al. Pharmacodynamics of a single low dose of long-acting recombinant follicle-stimulating hormone (FSH-carboxy terminal peptide, corifollitropin alfa) in women with World Health Organization group II anovulatory infertility. J. Clin. Endocrinol. Metab. 89, 6297-6304 (2004).
-
(2004)
J. Clin. Endocrinol. Metab.
, vol.89
, pp. 6297-6304
-
-
Balen, A.H.1
-
15
-
-
0036773437
-
A group-comparative, randomized, double-blind comparison of the efcacy and efciency of two fxed daily dose regimens (100-and 200-IU) of recombinant follicle stimulating hormone (rFSH, Puregon) in Asian women undergoing ovarian stimulation for IVF/ICSI
-
Asian Purgeon Study Group
-
Hoomans, E.H. & Mulder, B.B.; Asian Purgeon Study Group. A group-comparative, randomized, double-blind comparison of the efcacy and efciency of two fxed daily dose regimens (100-and 200-IU) of recombinant follicle stimulating hormone (rFSH, Puregon) in Asian women undergoing ovarian stimulation for IVF/ICSI. J. Assist. Reprod. Genet. 19, 470-476 (2002).
-
(2002)
J. Assist. Reprod. Genet.
, vol.19
, pp. 470-476
-
-
Hoomans, E.H.1
Mulder, B.B.2
-
16
-
-
0032997924
-
A prospective, randomized, double-blind clinical trial to study the efcacy and efciency of a fxed dose of recombinant follicle stimulating hormone (Puregon) in women undergoing ovarian stimulation
-
Out, H.J. et al. A prospective, randomized, double-blind clinical trial to study the efcacy and efciency of a fxed dose of recombinant follicle stimulating hormone (Puregon) in women undergoing ovarian stimulation. Hum. Reprod. 14, 622-627 (1999).
-
(1999)
Hum. Reprod.
, vol.14
, pp. 622-627
-
-
Out, H.J.1
-
17
-
-
0033963346
-
Increasing the daily dose of recombinant follicle stimulating hormone (Puregon) does not compensate for the age-related decline in retrievable oocytes after ovarian stimulation
-
Out, H.J. et al. Increasing the daily dose of recombinant follicle stimulating hormone (Puregon) does not compensate for the age-related decline in retrievable oocytes after ovarian stimulation. Hum. Reprod. 15, 29-35 (2000).
-
(2000)
Hum. Reprod.
, vol.15
, pp. 29-35
-
-
Out, H.J.1
-
18
-
-
0034969673
-
A randomized, double-blind clinical trial using fxed daily doses of 100 or 200 IU of recombinant FSH in ICSI cycles
-
Out, H.J. et al. A randomized, double-blind clinical trial using fxed daily doses of 100 or 200 IU of recombinant FSH in ICSI cycles. Hum. Reprod. 16, 1104-1109 (2001)
-
(2001)
Hum. Reprod.
, vol.16
, pp. 1104-1109
-
-
Out, H.J.1
-
19
-
-
0034755127
-
A double-blind clinical trial comparing a fxed daily dose of 150 and 250 IU of recombinant follicle-stimulating hormone in women undergoing in vitro fertilization
-
Latin American Puregon Study Group
-
Latin American Puregon Study Group. A double-blind clinical trial comparing a fxed daily dose of 150 and 250 IU of recombinant follicle-stimulating hormone in women undergoing in vitro fertilization. Fertil. Steril. 76, 950-956 (2001).
-
(2001)
Fertil. Steril.
, vol.76
, pp. 950-956
-
-
-
20
-
-
0033807688
-
Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is efective, safe and convenient: Results of a controlled, randomized, multicentre trial
-
The European Orgalutran Study Group
-
Borm, G. & Mannaerts, B. Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is efective, safe and convenient: results of a controlled, randomized, multicentre trial. The European Orgalutran Study Group. Hum. Reprod. 15, 1490-1498 (2000).
-
(2000)
Hum. Reprod.
, vol.15
, pp. 1490-1498
-
-
Borm, G.1
Mannaerts, B.2
-
21
-
-
0035161913
-
Efcacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulation
-
North American Ganirelix Study Group
-
Fluker, M. et al.; North American Ganirelix Study Group. Efcacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulation. Fertil. Steril. 75, 38-45 (2001)
-
(2001)
Fertil. Steril.
, vol.75
, pp. 38-45
-
-
Fluker, M.1
-
22
-
-
0035070776
-
Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation
-
European and Middle East Orgalutran Study Group
-
European and Middle East Orgalutran Study Group. Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation. Hum. Reprod. 16, 644-651 (2001).
-
(2001)
Hum. Reprod.
, vol.16
, pp. 644-651
-
-
-
23
-
-
29144499138
-
A comparative randomized trial to assess the impact of oral contraceptive pretreatment on follicular growth and hormone profles in GnRH antagonist-treated patients
-
Orgalutran Scheduling Study Group
-
Rombauts, L., Healy, D. & Norman, R.J.; Orgalutran Scheduling Study Group. A comparative randomized trial to assess the impact of oral contraceptive pretreatment on follicular growth and hormone profles in GnRH antagonist-treated patients. Hum. Reprod. 21, 95-103 (2006).
-
(2006)
Hum. Reprod.
, vol.21
, pp. 95-103
-
-
Rombauts, L.1
Healy, D.2
Norman, R.J.3
|